Hernia Surgery Clinical Trials

Clinical trials related to Hernia Surgery Procedure

Effect of Medial Transversus Abdominis Plane (TAP) Block and Rectus Sheath (RS) Block on Inguinal Hernia Surgery Recovery, a Prospective Randomized Double-blind Study (PRO-RSTAP)

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Drug, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Inguinal hernia repair is a common surgical procedure, often performed as day-case surgery. Despite standardized surgical techniques, postoperative pain may delay recovery and occasionally lead to unplanned hospital admission. The PRO-RSTAP study is a prospective, randomized, double-blind clinical trial evaluating whether ultrasound-guided transversus abdominis plane (TAP) block, rectus sheath (RS) block, or their combination improves postoperative recovery after open inguinal hernia surgery. Adult patients undergoing unilateral open inguinal hernia repair are randomized into four groups receiving either combined TAP and RS blocks, TAP block only, RS block only, or placebo blocks , in addition to standard perioperative care. The primary outcome is total perioperative opioid consumption measured as intravenous morphine equivalents. Secondary outcomes include postoperative pain scores, need for rescue analgesia, postoperative nausea and vomiting, time to discharge, unplanned hospital admission, and chronic postoperative pain during long-term follow-up. The aim of this study is to determine the individual and combined effects of TAP and RS blocks on postoperative analgesia and recovery in patients undergoing open inguinal hernia repair.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults aged 18 years or older

• Elective unilateral open inguinal hernia repair

• Ability to provide written informed consent

Locations
Other Locations
Finland
Tampere University Hospital
RECRUITING
Tampere
Contact Information
Primary
Aki Lumme, MD
aki.lumme@pirha.fi
+358331167232
Time Frame
Start Date: 2025-07-01
Estimated Completion Date: 2038-01
Participants
Target number of participants: 200
Treatments
Experimental: Combined TAP + RS block
Participants receive active TAP block and active RS block in addition to standard perioperative care.
Experimental: TAP block only
Participants receive active TAP block and placebo RS block in addition to standard perioperative care.
Experimental: RS block only
Participants receive active RS block and placebo TAP block in addition to standard perioperative care.
Placebo_comparator: Placebo TAP + Placebo RS
Participants receive placebo transversus abdominis plane (TAP) block and placebo rectus sheath (RS) block in addition to standard perioperative care.
Related Therapeutic Areas
Sponsors
Leads: Tampere University Hospital

This content was sourced from clinicaltrials.gov